Bliss GVS Pharma, 506197, BLISSGVS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,068.90
39.25
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,904.96
0.31%
4.29

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

1.51
4.40
6.37

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-3.02
4.75
-0.19

PAT CAGR (%)

10 Years
5 Years
3 Years

4.64
53.73
19.61

P:E (Median)

8 Years
5 Years
3 Years

16.58
16.61
16.62

P:BV (Average)

8 Years
5 Years
3 Years

1.68
1.41
1.65

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.07
7.52
8.74

Earnings Forecasts:

(Updated: 01-08-2026)

Description 2026 2027 2028 2029
Adj EPS 78 -1 - -
P/E Ratio 6.12 -477.55 - -
Revenue - - - -
EBITDA - - - -
Net Income - - - -
ROA - - - -
P/B Ratio - - - -
ROE - - - -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 211.54 156.00 35.60% 164.68 179.59 -8.30% 190.22 182.65 4.14% 163.36 148.96 9.67%
Expenses 167.39 142.27 17.66% 137.83 153.86 -10.42% 172.21 159.00 8.31% 130.60 122.22 6.86%
EBITDA 44.15 13.73 221.56% 26.85 25.73 4.35% 18.02 23.64 -23.77% 32.77 26.74 22.55%
EBIDTM 20.87% 8.80% 16.30% 14.33% 9.47% 12.94% 20.06% 17.95%
Other Income 9.30 9.36 -0.64% 10.23 11.66 -12.26% 25.84 10.09 156.10% 10.59 6.84 54.82%
Interest 1.81 1.30 39.23% 1.48 0.67 120.90% 2.71 3.45 -21.45% 5.11 1.17 336.75%
Depreciation 7.84 7.43 5.52% 7.80 6.96 12.07% 7.69 6.40 20.16% 7.68 6.26 22.68%
PBT 44.15 14.36 207.45% 25.29 29.77 -15.05% 33.45 23.89 40.02% 30.56 26.15 16.86%
Tax 11.73 2.91 303.09% 6.68 8.72 -23.39% 8.66 6.85 26.42% 9.51 6.73 41.31%
PAT 32.42 11.45 183.14% 18.61 21.05 -11.59% 24.79 17.04 45.48% 21.05 19.42 8.39%
PATM 15.33% 7.34% 11.30% 11.72% 13.03% 9.33% 12.89% 13.04%
EPS 3.06 1.08 183.33% 1.75 1.98 -11.62% 2.34 1.61 45.34% 1.98 1.83 8.20%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 256.99 197.99 29.80% 218.25 210.42 3.72% 244.40 217.68 12.27% 207.47 183.64 12.98%
Expenses 212.55 176.90 20.15% 183.46 180.63 1.57% 212.64 177.94 19.50% 166.14 149.31 11.27%
EBITDA 44.44 21.09 110.72% 34.79 29.79 16.78% 31.76 39.74 -20.08% 41.33 34.33 20.39%
EBIDTM 17.29% 10.65% 15.94% 14.16% 12.99% 18.26% 19.92% 18.69%
Other Income 11.16 12.07 -7.54% 18.46 15.27 20.89% 20.18 6.78 197.64% 35.45 4.12 760.44%
Interest 2.01 1.68 19.64% 1.49 1.08 37.96% 3.04 3.83 -20.63% 5.47 1.53 257.52%
Depreciation 8.67 8.04 7.84% 8.35 7.55 10.60% 8.26 6.98 18.34% 8.20 6.85 19.71%
PBT 44.95 23.44 91.77% 40.89 36.42 12.27% 40.63 35.71 13.78% 63.11 30.07 109.88%
Tax 7.95 6.79 17.08% 16.12 10.62 51.79% 12.04 10.01 20.28% 18.75 7.97 135.26%
PAT 37.00 16.65 122.22% 24.78 25.80 -3.95% 28.59 25.69 11.29% 44.36 22.11 100.63%
PATM 14.40% 8.41% 11.35% 12.26% 11.70% 11.80% 21.38% 12.04%
EPS 3.36 1.47 128.57% 2.20 2.26 -2.65% 2.58 2.31 11.69% 4.08 1.97 107.11%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales - 729.81 667.20 605.46 598.34 636.36 465.51 441.95 426.59 297.89 348.02 Net Sales Growth - 9.38% 10.20% 1.19% -5.97% 36.70% 5.33% 3.60% 43.20% -14.40% Cost Of Goods Sold - 342.63 346.10 299.47 314.90 343.94 253.30 236.73 225.15 145.81 167.21 Gross Profit - 387.17 321.10 305.99 283.44 292.41 212.21 205.23 201.44 152.08 180.80 GP Margin - 53.05% 48.13% 50.54% 47.37% 45.95% 45.59% 46.44% 47.22% 51.05% 51.95% Total Expenditure - 610.58 575.62 498.29 508.18 527.16 374.05 341.78 333.49 209.43 247.49 Power & Fuel Cost - 12.95 9.76 8.81 5.80 7.09 6.99 4.70 3.57 2.59 2.73 % Of Sales - 1.77% 1.46% 1.46% 0.97% 1.11% 1.50% 1.06% 0.84% 0.87% 0.78% Employee Cost - 121.50 99.42 82.59 72.54 65.06 58.61 44.02 33.85 26.29 25.03 % Of Sales - 16.65% 14.90% 13.64% 12.12% 10.22% 12.59% 9.96% 7.94% 8.83% 7.19% Manufacturing Exp. - 20.05 15.50 17.25 11.09 10.91 7.13 5.97 4.24 3.64 3.31 % Of Sales - 2.75% 2.32% 2.85% 1.85% 1.71% 1.53% 1.35% 0.99% 1.22% 0.95% General & Admin Exp. - 20.81 15.31 11.61 10.88 12.00 8.70 10.33 13.71 11.11 11.73 % Of Sales - 2.85% 2.29% 1.92% 1.82% 1.89% 1.87% 2.34% 3.21% 3.73% 3.37% Selling & Distn. Exp. - 58.48 62.92 55.12 56.50 55.70 28.56 26.16 31.07 14.77 26.29 % Of Sales - 8.01% 9.43% 9.10% 9.44% 8.75% 6.14% 5.92% 7.28% 4.96% 7.55% Miscellaneous Exp. - 34.15 26.61 23.44 36.48 32.45 10.76 13.88 21.91 5.22 26.29 % Of Sales - 4.68% 3.99% 3.87% 6.10% 5.10% 2.31% 3.14% 5.14% 1.75% 3.21% EBITDA - 119.23 91.58 107.17 90.16 109.20 91.46 100.17 93.10 88.46 100.53 EBITDA Margin - 16.34% 13.73% 17.70% 15.07% 17.16% 19.65% 22.67% 21.82% 29.70% 28.89% Other Income - 58.52 36.22 33.50 50.77 32.63 19.41 37.00 35.81 10.99 9.08 Interest - 11.11 6.58 5.81 10.06 4.32 5.92 6.62 3.15 6.95 9.07 Depreciation - 31.02 27.05 23.52 15.17 13.85 13.76 8.83 5.75 5.67 5.62 PBT - 135.62 94.17 111.34 115.69 123.66 91.19 121.71 120.01 86.84 94.91 Tax - 36.59 25.20 19.61 30.21 33.74 23.69 29.38 45.58 29.82 35.77 Tax Rate - 27.42% 26.76% 27.91% 26.11% 26.69% 25.98% 24.14% 37.98% 34.34% 37.69% PAT - 96.87 68.97 50.64 85.48 92.66 67.50 92.33 74.43 57.01 59.13 PAT before Minority Interest - 96.87 68.97 50.64 85.48 92.66 67.50 92.33 74.43 57.01 59.13 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 13.27% 10.34% 8.36% 14.29% 14.56% 14.50% 20.89% 17.45% 19.14% 16.99% PAT Growth - 40.45% 36.20% -40.76% -7.75% 37.27% -26.89% 24.05% 30.56% -3.59% EPS - 9.13 6.50 4.77 8.06 8.73 6.36 8.70 7.02 5.37 5.57

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales - 927.11 809.73 770.24 751.59 747.45 577.21 689.31 898.57 814.64 798.44 Net Sales Growth - 14.50% 5.13% 2.48% 0.55% 29.49% -16.26% -23.29% 10.30% 2.03% Cost Of Goods Sold - 425.07 413.69 382.11 401.32 390.98 329.71 439.97 612.26 391.13 358.93 Gross Profit - 502.05 396.04 388.13 350.26 356.47 247.49 249.34 286.31 423.52 439.51 GP Margin - 54.15% 48.91% 50.39% 46.60% 47.69% 42.88% 36.17% 31.86% 51.99% 55.05% Total Expenditure - 777.88 683.04 619.62 634.26 629.11 470.56 565.99 740.93 617.50 595.70 Power & Fuel Cost - 14.23 11.33 10.43 7.13 8.25 8.14 5.88 4.76 5.49 5.58 % Of Sales - 1.53% 1.40% 1.35% 0.95% 1.10% 1.41% 0.85% 0.53% 0.67% 0.70% Employee Cost - 136.43 112.05 95.58 86.17 76.15 68.09 53.69 42.32 69.23 61.35 % Of Sales - 14.72% 13.84% 12.41% 11.47% 10.19% 11.80% 7.79% 4.71% 8.50% 7.68% Manufacturing Exp. - 22.74 16.83 18.59 12.24 12.09 7.83 7.07 4.95 4.88 5.39 % Of Sales - 2.45% 2.08% 2.41% 1.63% 1.62% 1.36% 1.03% 0.55% 0.60% 0.68% General & Admin Exp. - 27.58 20.73 17.48 16.50 15.03 12.03 13.27 17.05 39.48 36.36 % Of Sales - 2.97% 2.56% 2.27% 2.20% 2.01% 2.08% 1.93% 1.90% 4.85% 4.55% Selling & Distn. Exp. - 93.97 73.58 68.41 63.95 67.18 31.35 28.83 34.72 62.09 92.46 % Of Sales - 10.14% 9.09% 8.88% 8.51% 8.99% 5.43% 4.18% 3.86% 7.62% 11.58% Miscellaneous Exp. - 57.86 34.84 27.02 46.96 59.43 13.40 17.28 24.86 45.21 92.46 % Of Sales - 6.24% 4.30% 3.51% 6.25% 7.95% 2.32% 2.51% 2.77% 5.55% 4.46% EBITDA - 149.23 126.69 150.62 117.33 118.34 106.65 123.32 157.64 197.14 202.74 EBITDA Margin - 16.10% 15.65% 19.55% 15.61% 15.83% 18.48% 17.89% 17.54% 24.20% 25.39% Other Income - 88.33 36.49 28.74 17.79 31.49 21.95 39.19 37.63 26.54 12.51 Interest - 12.01 8.12 6.91 10.36 4.74 7.24 7.57 4.41 22.80 19.69 Depreciation - 33.48 29.42 26.38 18.67 17.33 17.23 12.59 8.94 21.38 20.14 PBT - 192.08 125.64 146.07 106.07 127.76 104.13 142.35 181.92 179.49 175.40 Tax - 54.86 35.38 35.29 29.34 31.04 30.16 33.71 55.25 56.63 62.72 Tax Rate - 28.94% 28.16% 30.20% 27.66% 57.30% 28.96% 26.14% 30.37% 38.98% 35.76% PAT - 129.13 84.30 75.46 70.85 15.04 68.49 97.26 123.72 58.78 82.04 PAT before Minority Interest - 134.73 90.26 81.58 76.73 23.13 73.97 95.25 126.66 88.66 112.68 Minority Interest - -5.60 -5.96 -6.12 -5.88 -8.09 -5.48 2.01 -2.94 -29.88 -30.64 PAT Margin - 13.93% 10.41% 9.80% 9.43% 2.01% 11.87% 14.11% 13.77% 7.22% 10.28% PAT Growth - 53.18% 11.71% 6.51% 371.08% -78.04% -29.58% -21.39% 110.48% -28.35% EPS - 12.17 7.95 7.11 6.68 1.42 6.46 9.17 11.66 5.54 7.73

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,155.19 1,058.63 988.44 937.00 851.43 755.65 682.94 603.27 541.42 491.64 Share Capital 10.58 10.54 10.47 10.42 10.37 10.31 10.31 10.31 10.31 10.31 Total Reserves 1,132.95 1,041.80 970.25 917.69 831.12 735.50 672.63 592.96 531.11 481.33 Non-Current Liabilities 5.30 27.42 42.82 49.34 35.71 43.87 46.66 40.60 15.73 22.84 Secured Loans 0.00 19.67 35.10 40.69 23.22 32.49 35.55 30.53 5.55 12.47 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.00 4.36 2.60 2.61 1.07 2.50 2.44 1.75 1.91 1.81 Current Liabilities 168.59 125.00 114.89 153.36 192.83 146.11 125.50 91.98 136.85 151.82 Trade Payables 96.26 60.32 54.47 75.87 84.21 66.78 55.95 30.87 35.34 63.80 Other Current Liabilities 63.61 60.77 49.15 50.72 62.46 42.36 32.75 23.47 11.81 11.84 Short Term Borrowings 0.00 3.42 10.74 25.02 41.47 35.38 35.94 36.64 82.53 61.50 Short Term Provisions 8.72 0.49 0.54 1.74 4.69 1.59 0.87 1.01 7.18 14.68 Total Liabilities 1,329.08 1,211.05 1,146.15 1,139.70 1,079.97 945.63 855.10 735.85 694.00 666.30 Net Block 419.54 367.89 329.95 324.82 224.31 174.10 178.86 78.32 72.48 75.34 Gross Block 554.54 477.72 413.45 385.02 269.54 210.93 202.33 93.44 83.40 80.85 Accumulated Depreciation 135.00 109.84 83.50 60.21 45.22 36.84 23.47 15.12 10.92 5.51 Non Current Assets 502.72 445.31 373.92 410.04 288.22 268.98 212.46 157.95 117.72 111.50 Capital Work in Progress 4.40 20.58 7.83 2.80 22.15 2.39 0.00 42.91 0.47 1.98 Non Current Investment 18.69 18.69 18.69 18.26 18.26 18.30 19.00 19.01 19.17 21.54 Long Term Loans & Adv. 28.10 18.63 14.27 17.18 22.44 11.35 13.36 17.38 25.31 12.23 Other Non Current Assets 31.31 18.84 2.50 46.30 0.37 62.15 1.24 0.33 0.29 0.42 Current Assets 826.36 765.74 772.23 729.65 791.74 676.64 642.65 577.90 576.29 554.80 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 110.92 81.94 89.45 74.15 90.11 83.68 60.57 54.84 39.80 28.06 Sundry Debtors 457.12 428.70 399.51 399.06 408.82 348.68 404.91 342.09 282.54 239.41 Cash & Bank 110.60 171.11 169.32 84.61 149.48 119.52 86.62 93.29 70.29 83.57 Other Current Assets 147.73 24.59 25.74 14.15 143.32 124.76 90.55 87.68 183.65 203.76 Short Term Loans & Adv. 120.80 59.40 88.22 157.68 126.55 101.48 74.25 62.40 143.27 173.39 Net Current Assets 657.77 640.74 657.34 576.30 598.91 530.54 517.15 485.92 439.44 402.98 Total Assets 1,329.08 1,211.05 1,146.15 1,139.69 1,079.96 945.62 855.11 735.85 694.01 666.30

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,192.90 1,050.38 967.19 883.90 818.70 808.25 735.61 646.00 536.24 486.62 Share Capital 10.58 10.54 10.47 10.42 10.37 10.31 10.31 10.31 10.31 10.31 Total Reserves 1,170.66 1,033.54 949.00 864.59 798.40 788.10 725.30 635.68 525.92 476.31 Non-Current Liabilities 8.81 37.28 51.20 42.84 29.20 45.24 46.32 37.99 12.92 32.81 Secured Loans 0.00 19.85 35.59 40.69 23.22 32.60 37.24 32.54 5.92 25.58 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.41 4.36 2.67 2.69 1.07 2.50 2.44 1.75 1.91 2.05 Current Liabilities 235.54 172.16 157.41 193.26 233.09 203.64 230.53 207.03 299.40 437.09 Trade Payables 104.21 71.42 60.97 86.39 92.61 74.22 89.92 78.88 58.43 98.25 Other Current Liabilities 93.83 73.44 62.46 58.20 67.85 53.69 57.21 50.24 124.46 99.93 Short Term Borrowings 2.75 22.89 32.12 46.01 60.70 65.04 66.39 64.30 105.66 187.47 Short Term Provisions 34.75 4.42 1.87 2.66 11.93 10.69 17.01 13.61 10.85 51.45 Total Liabilities 1,476.11 1,301.29 1,211.59 1,153.53 1,108.75 1,076.79 1,027.22 904.88 860.04 1,022.90 Net Block 458.61 404.95 369.37 378.05 280.76 233.72 240.97 144.97 136.48 303.86 Gross Block 607.42 531.06 467.78 458.74 343.41 285.10 276.07 169.89 157.47 326.83 Accumulated Depreciation 148.82 126.11 98.41 80.69 62.65 51.38 35.10 24.92 20.99 22.97 Non Current Assets 529.78 477.46 400.72 456.15 331.89 311.59 257.48 211.39 170.25 456.97 Capital Work in Progress 6.05 20.71 7.83 2.80 22.15 2.39 0.00 46.74 0.47 4.03 Non Current Investment 3.52 4.38 3.61 2.84 2.39 0.01 0.72 0.72 6.30 1.05 Long Term Loans & Adv. 29.54 19.77 14.72 17.62 24.42 12.63 14.56 18.63 26.72 11.45 Other Non Current Assets 31.38 26.96 4.50 54.16 1.47 62.15 1.24 0.33 0.29 136.58 Current Assets 946.34 816.66 810.87 697.37 776.86 765.20 769.74 693.49 689.79 565.93 Current Investments 1.45 0.00 0.56 4.96 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 150.73 125.73 118.45 103.06 123.94 98.93 74.14 77.37 59.03 49.30 Sundry Debtors 517.19 438.80 404.35 385.17 392.75 463.82 547.91 460.73 298.48 254.45 Cash & Bank 166.87 213.31 215.62 102.99 177.53 144.55 103.32 106.63 88.86 150.50 Other Current Assets 110.10 14.67 17.01 6.63 82.64 57.90 44.37 48.76 243.41 111.68 Short Term Loans & Adv. 96.40 24.15 54.90 94.56 68.52 40.35 28.24 22.55 146.30 78.44 Net Current Assets 710.79 644.49 653.47 504.11 543.77 561.56 539.21 486.47 390.39 128.84 Total Assets 1,476.12 1,294.12 1,211.59 1,153.52 1,108.75 1,076.79 1,027.22 904.88 860.04 1,022.90

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 123.16 97.21 82.17 43.81 114.05 66.97 63.22 48.29 22.67 38.48 PBT 133.46 94.17 111.34 115.69 123.66 91.19 121.71 120.01 86.84 94.91 Adjustment 70.33 56.44 44.25 41.42 35.10 41.14 3.43 3.36 0.77 28.12 Changes in Working Capital -42.18 -23.08 -44.08 -75.58 -14.23 -42.64 -30.07 -25.53 -29.06 -47.37 Cash after chg. in Working capital 161.61 127.53 111.51 81.53 144.52 89.69 95.08 97.84 58.54 75.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -38.46 -30.33 -29.34 -37.72 -30.47 -22.72 -31.86 -49.55 -35.87 -37.17 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -51.40 -77.87 -65.84 -12.97 -92.28 -61.62 -60.14 -68.04 16.36 -29.34 Net Fixed Assets -60.64 -77.02 -33.46 -96.13 -78.37 -10.99 -65.98 -52.48 -1.04 42.08 Net Investments 0.00 0.00 -0.43 0.00 0.04 0.70 0.01 0.16 2.37 -0.95 Others 9.24 -0.85 -31.95 83.16 -13.95 -51.33 5.83 -15.72 15.03 -70.47 Cash from Financing Activity -75.37 -26.56 -20.76 -26.05 -12.62 -11.67 -5.83 9.05 -21.91 -14.77 Net Cash Inflow / Outflow -3.61 -7.23 -4.43 4.79 9.14 -6.33 -2.75 -10.70 17.12 -5.63 Opening Cash & Equivalents 6.85 14.17 18.60 13.82 4.67 11.00 13.75 24.45 7.33 12.95 Closing Cash & Equivalent 3.33 6.85 14.17 18.60 13.82 4.67 11.00 13.75 24.45 7.33

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 138.72 105.91 102.82 34.31 135.48 63.97 46.70 39.95 17.64 289.47 PBT 189.59 125.64 146.07 106.07 127.76 104.13 128.97 181.91 179.49 175.40 Adjustment 95.87 70.75 38.17 57.92 -31.71 46.29 26.85 -10.97 17.55 36.24 Changes in Working Capital -104.45 -51.46 -46.57 -85.12 73.37 -57.89 -70.32 -183.07 -140.80 113.48 Cash after chg. in Working capital 181.01 144.93 137.67 78.87 169.42 92.53 85.49 -12.13 56.24 325.13 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -41.65 -36.64 -34.85 -44.56 -33.94 -28.56 -38.79 52.08 -38.61 -35.66 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -0.64 -2.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -38.28 -75.59 -83.19 -7.75 -92.98 -46.99 -47.89 -73.52 50.24 -231.25 Net Fixed Assets -60.64 -77.02 -33.46 -96.13 -78.37 -10.99 -65.98 -52.48 -1.04 42.08 Net Investments 0.00 0.00 -0.43 0.00 0.04 0.70 0.01 0.16 2.37 -0.95 Others 22.36 1.43 -49.30 88.38 -14.65 -36.70 18.08 -21.20 48.91 -272.38 Cash from Financing Activity -89.21 -30.20 -20.89 -24.94 -23.73 -20.80 -6.30 16.83 -75.98 -10.13 Net Cash Inflow / Outflow 11.23 0.13 -1.27 1.62 18.78 -3.82 -7.50 -16.74 -8.10 48.09 Opening Cash & Equivalents 23.82 23.59 25.01 21.99 13.13 15.34 15.04 36.95 47.41 0.00 Closing Cash & Equivalent 35.14 23.82 23.59 25.01 21.99 13.13 15.34 15.04 36.95 47.41

Financial Ratios

Consolidated /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 108.10 99.87 93.68 89.11 81.16 72.31 66.21 58.49 52.49 47.66 ROA 7.63% 5.85% 4.43% 7.70% 9.15% 7.50% 11.61% 10.41% 8.38% 8.67% ROE 8.82% 6.78% 5.31% 9.66% 11.68% 9.45% 14.36% 13.00% 11.04% 12.80% ROCE 12.77% 9.31% 7.36% 12.89% 14.68% 12.02% 17.75% 18.80% 15.60% 19.25% Fixed Asset Turnover 1.50 1.57 1.52 1.83 2.65 2.25 2.99 4.82 3.63 3.44 Receivable days 209.20 215.90 240.71 246.41 217.24 295.44 308.46 267.22 319.34 255.29 Inventory Days 45.55 44.68 49.31 50.10 49.84 56.55 47.66 40.49 41.51 26.05 Payable days 83.40 60.52 79.43 92.78 80.11 88.42 48.84 39.16 90.96 75.73 Cash Conversion Cycle 171.35 200.06 210.59 203.74 186.97 263.57 307.29 268.56 269.89 205.62 Total Debt/Equity 0.00 0.05 0.07 0.08 0.10 0.12 0.13 0.12 0.17 0.15 Interest Cover 13.01 15.30 13.10 12.50 30.23 16.40 19.38 39.08 13.49 11.46

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 111.66 99.09 91.65 84.01 78.01 77.41 71.32 62.63 51.99 47.18 ROA 9.70% 7.18% 6.90% 6.78% 2.12% 7.03% 9.86% 14.35% 9.42% 11.88% ROE 12.11% 9.01% 8.89% 9.11% 2.88% 9.64% 13.79% 21.43% 17.34% 25.06% ROCE 17.40% 12.29% 12.15% 12.22% 6.37% 12.49% 17.02% 26.58% 24.61% 31.06% Fixed Asset Turnover 1.70 1.69 1.66 1.87 2.38 2.06 3.09 5.49 3.37 2.56 Receivable days 180.13 182.64 187.07 188.89 209.14 319.89 267.05 154.20 123.80 126.33 Inventory Days 52.09 52.89 52.48 55.12 54.42 54.72 40.11 27.70 24.25 20.01 Payable days 75.40 58.40 70.38 81.40 77.87 90.85 56.62 35.01 51.74 67.63 Cash Conversion Cycle 156.82 177.13 169.17 162.62 185.69 283.75 250.53 146.89 96.31 78.70 Total Debt/Equity 0.00 0.07 0.09 0.11 0.13 0.15 0.16 0.16 0.22 0.46 Interest Cover 16.79 16.47 17.91 11.23 12.42 15.38 18.04 42.21 7.37 9.91

Top Investors:

gulbarga trading and investment private

arjun gautam ashra .

clarus capital i

life insurance corporation of india

gautam rasiklal ashra

investor education and protection fund authority ministry of corporate affairs

llp

coeus global opportunities fund

arian investment limited

360 one pipe fund

Annual Reports:

News Update:

Bliss GVS Pharma secures Inspection Closure Report from WHO
3rd Jun 2026, 14:59 PM

The company’s Palghar facility has been confirmed to be in compliance with the GMP standards published by WHO
Read More

Bliss GVS Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506197 | NSE: BLISSGVS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Bliss GVS Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506197 | NSE: BLISSGVS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: